Healthcare -
Biotechnology - NASDAQ - US
$ 0.6772
0.296 %
$ 53 M
Market Cap
4.23
P/E
CTMX - SHORT-TERM DEBT
Short-term Debt CTMX - CytomX Therapeutics, Inc.
4.59 M
LAST VALUE
12.62%
2 YEAR CAGR
0.00%
5 YEAR CAGR
13.82%
10 YEAR CAGR